相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study
Yi-Wen Huang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)
Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C-Related Compensated Cirrhosis
Arpan Mohanty et al.
GASTROENTEROLOGY (2016)
Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis
Juan G. Abraldes et al.
GASTROENTEROLOGY (2016)
Recurrent Alcoholic Cirrhosis In Severe Alcoholic Relapse After Liver Transplantation: A Frequent and Serious Complication
Jerome Dumortier et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C
Tracey G. Simon et al.
JOURNAL OF HEPATOLOGY (2015)
Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection
Yao-Hsu Yang et al.
JOURNAL OF HEPATOLOGY (2015)
KLF2 exerts antifibrotic and vasoprotective effects in cirrhotic rat livers: behind the molecular mechanisms of statins
Giusi Marrone et al.
GUT (2015)
A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology
Kenneth G. Linden et al.
CANCER PREVENTION RESEARCH (2014)
Statin Use in Patients with Cirrhosis: A Retrospective Cohort Study
Sonal Kumar et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Vascular pathobiology in chronic liver disease and cirrhosis - Current status and future directions
Yasuko Iwakiri et al.
JOURNAL OF HEPATOLOGY (2014)
Challenges of Guarantee-Time Bias
Anita Giobbie-Hurder et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
Yu-Tse Tsan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Increased incidence of orthopedic fractures in cirrhotic patients: A nationwide population-based study
Chia-Fen Tsai et al.
JOURNAL OF HEPATOLOGY (2013)
The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins
Giusi Marrone et al.
JOURNAL OF HEPATOLOGY (2013)
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus Infection
Yu-Tse Tsan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Long-term survival and predictors for mortality among dialysis patients in an endemic area for chronic liver disease: a national cohort study in Taiwan
Chih-Chiang Chien et al.
BMC NEPHROLOGY (2012)
Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C
Gowtham A. Rao et al.
GASTROENTEROLOGY (2011)
Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan
Ching-Lan Cheng et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization
Marwan M. Azar et al.
DRUG AND ALCOHOL DEPENDENCE (2010)
Histamine2-Receptor Antagonists Are an Alternative to Proton Pump Inhibitor in Patients Receiving Clopidogrel
Chun-Ying Wu et al.
GASTROENTEROLOGY (2010)
Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
Juan G. Abraldes et al.
GASTROENTEROLOGY (2009)
Statins Potentiate the In Vitro Anti-Hepatitis C Virus Activity of Selective Hepatitis C Virus Inhibitors and Delay or Prevent Resistance Development
Leen Delang et al.
HEPATOLOGY (2009)
Statins, Stem Cells, and Cancer
Kalamegam Gauthaman et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Fluvastatin inhibits hepatitis C replication in humans
Ted Bader et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Simvastatin has an anti-inflammatory effect on macrophages via upregulation of an atheroprotective transcription factor, Kruppel-like factor 2
Tiina T. Tuomisto et al.
CARDIOVASCULAR RESEARCH (2008)
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis
Cristina Ripoll et al.
GASTROENTEROLOGY (2007)
Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase
Jonel Trebicka et al.
HEPATOLOGY (2007)
Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats
Juan G. Abraldes et al.
JOURNAL OF HEPATOLOGY (2007)
Different anti-HCV profiles of statins and their potential for combination therapy with interferon
Masanori Ikeda et al.
HEPATOLOGY (2006)
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
G D'Amico et al.
JOURNAL OF HEPATOLOGY (2006)
A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension
SL Liu et al.
NATURE MEDICINE (2005)
Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes - New evidence for direct antiinflammatory effects of statins
C Arnaud et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis
C Zafra et al.
GASTROENTEROLOGY (2004)
KLF2 is a novel transcriptional regulator of endothelial proinflammatory activation
S SenBanerjee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter?
GP Pageaux et al.
JOURNAL OF HEPATOLOGY (2003)
3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis
T Kusama et al.
GASTROENTEROLOGY (2002)
分享论文
